Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myeloid, Acute × obinutuzumab × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 24 Lymphoma, Follicular 15 Lymphoma, Non-Hodgkin 9 Lymphoma, Large B-Cell, Diffuse 8 Lymphoma, Mantle-Cell 5 Lymphoma 5 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma, B-Cell 3 Leukemia 3 Neoplasms 2 Bronchiolitis Obliterans Syndrome 2 Tumor Lysis Syndrome 1 Solid Tumors 1 Recurrence 1 Oncology Patients Receiving Chemotherapy 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Leukemia, Prolymphocytic, B-Cell 1 Leukemia, Lymphoid 1 Leukemia, Hairy Cell 1 Indolent Non-Hodgkin's Lymphoma 1 Chromosome 17 deletion 1 Carcinoma, Non-Small-Cell Lung 1 B-cell Malignancies 1 Anemia 1

Interventions

Cytarabine 146 fludarabine phosphate 85 Cyclophosphamide 83 Azacitidine 80 fludarabine 66 Whole-Body Irradiation 64 Mycophenolic Acid 57 Busulfan 54 Decitabine 50 Tacrolimus 42 Peripheral Blood Stem Cell Transplantation 41 Granulocyte Colony-Stimulating Factor 39 Filgrastim 38 Clofarabine 37 Melphalan 36 Idarubicin 36 Etoposide 36 Cyclosporine 36 Daunorubicin 35 Mitoxantrone 31 Methotrexate 31 Antilymphocyte Serum 29 venetoclax 28 thymoglobulin 22 Stem Cell Transplantation 19 Thiotepa 18 Gemtuzumab 15 CPX-351 15 Cord Blood Stem Cell Transplantation 14 Sirolimus 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡